SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series January recently filed with US Patent Office 01/12

20120022241 - Sophorolipid analog compositions: A composition of matter comprising sophorolipids as antimicrobial agents, antifungal agents, biopesticides, for uses as drugs to treat HIV, septic shock, cancer, asthma, dermatological conditions, as spermicidal agents, as anti-inflammatory drugs, as ingredients in cosmetics and building blocks for monomers and polymers and self-assembled templates for further chemical elaboration.... Agent:

20120022242 - Method for producing an elongate polysaccharide element, in particular a chitosan thread, and polysacccharide thread obtained: The invention relates to a method for producing an elongate polysaccharide element, in particular a chitosan thread, comprising an operation of extruding an extrusible solution of said polysaccharide through an extrusion die and an operation of coagulating the extruded solution. The extrusible solution is a hydroalcoholic solution containing an alcohol... Agent: Universite Claude Bernad Lyon I

20120022243 - Biomolecular self-assembly: The present invention relates generally to programming of biomolecular self-assembly pathways and related methods and constructs for self-assembly of prescribed two and three-dimensional structures.... Agent:

20120022244 - Self-assembled polynucleotide structure: The present application provides polynucleotide structures such as nucleic acid ribbons and nucleic acid tubes, methods for making the polynucleotide structures, and methods for making two-dimensional or three-dimensional objects comprising the nucleic acid ribbons and nucleic acid tubes.... Agent:

20120022245 - Folate targeting of nucleotides: The present invention relates to compounds, compositions, kits, and methods of use in targeting nucleotides, such as siRNA's, to cancer cells or to immune system cells involved in inflammation. More particularly, the invention is directed to receptor binding ligand-nucleotide delivery conjugates for use in specifically targeting the conjugates to cancer... Agent: Endocyte, Inc.

20120022246 - Magnetic pigment: Magnetic particles with an outer glass surface being essentially poreless or having pores of a diameter of less then 10 nm as well as ferromagnetic particles with a glass surface are preferentially useful for the isolation of biological material from samples. They provide a quick and reliable purification.... Agent: Roche Molecular Systems, Inc.

20120022247 - Methods of purifying a nucleic acid and formulation and kit for use in performing such methods: A formulation containing guanidine thiocyanate together with acetamide, one or more acetamide derivatives, or a combination of acetamide and one or more acetamide derivatives is used to purify one or more nucleic acids contained in a medium. In particular, a medium containing at least one nucleic acid is combined with... Agent:

20120016114 - Process for the preparation of monoethylenically unsaturated glycosylamines: The present invention relates to a process for the preparation of monoethylenically unsaturated glycosylamines, in which an aldehyde sugar is reacted with a primary aliphatic amine or ammonia in aqueous medium and, without interim isolation, is reacted with the anhydride of a monounsaturated carboxylic acid, or an aldehyde sugar is... Agent: Basf Se

20120016115 - Apparatus for manufacturing gel particle and method for manufacturing gel particle: An apparatus for manufacturing gel particle according to an embodiment of the invention is an apparatus for manufacturing gel particle of a first liquid and a second liquid by delivering the droplets of the first liquid including a gel particle-forming material to the second liquid that becomes the gel particle... Agent: Seiko Epson Corporation

20120010391 - Bonding products of aminated polysaccharides: The invention relates to a bonding product comprising at least the polysaccharides T1 and T2, characterized in that a) the monosaccharides from which the polysaccharides T1 and T2 are constructed are partially or completely bonded to each other alpha-1,4-glycosidically and b) at least one of the polysaccharides T1 and/or T2... Agent: B. Braun Melsungen Ag

20120010393 - 5'-modified bicyclic nucleic acid analogs: The present invention provides 5′-modified bicyclic nucleoside analogs and oligomeric compounds comprising at least one of these nucleoside analogs. In preferred embodiments the nucleoside analogs have either (R) or (S)-chirality at the 5′-carbon. These bicyclic nucleoside analogs are useful for enhancing properties of oligomeric compounds including for example enhanced nuclease... Agent: Isis Pharmaceuticals, Inc.

20120010392 - Protein kinase-inducible domains: Applicants have used protein design to develop novel functional protein architectures, termed protein kinase-inducible domains, whose structures are dependent on phosphorylation by specific protein kinases or are dependent on dephosphorylation by specific protein phosphatases. Applicants have designed kinase-inducible domains based on a modular architecture, which allows kinase-inducible domains to be... Agent:

20120010394 - Immunogen platform: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including,... Agent: Chrontech Pharma Ab

20120010395 - Compositions, probes, and conjugates and uses thereof: The present invention relates to compositions useful as probes and in other applications and methods of their use. In some embodiments, nucleotides are prepared and functionalized with dyes. In some embodiments a first molecule is functionalized with an alkynyl group, a second molecule is functionalized with an azide group, and... Agent: Third Wave Technologies, Inc.

20120010396 - Production method of porous resin bead: The present invention provides a method for producing a porous resin bead containing an aromatic vinyl compound-hydroxystyrene-di(meth)acrylate copolymer, the method including: dissolving a monomer mixture containing an aromatic vinyl compound, an acyloxystyrene and a di(meth)acrylate compound, and a polymerization initiator in an organic solvent to obtain a solution containing the... Agent: Nitto Denko Corporation

20120010397 - Preparation of 2-chloro-9-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-adenine: e

20120010398 - Purification method: A process for purifying a Streptococcus pyogenes GAS carbohydrate comprising a step of anionic exchange chromatography. The process provides a good yield of GAS carbohydrate. The saccharides of the invention have low levels of hyaluronic acid, protein and nucleic acid contamination.... Agent: Novartis Ag

20120010399 - Biotechnological production of chondroitin: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.... Agent: Gnosis S.p.a.

20120004401 - Compositions comprising lipochitooligosaccharides: Compositions containing lipochitooligosaccharides are disclosed. The compositions can be used to treat the roots, leaves, or seeds of plants and can be applied in the soil, to plant foliage, or as a seed coating... Agent: E.i. Du Pont De Nemours And Company

20120004402 - Crh and pomc effects on animal growth: The present invention provides for selection of bovine animals that will display phenotypes associated with increased rates of growth. These phenotypes include hot carcass weight, average daily gain, shipping weight, end of test rib eye area, and adjusted weaning weight which is a measure of post-natal growth, based on the... Agent: University Of Saskatchewan

20120004403 - Rna interference mediated inhibition of tnf and tnf receptor gene expression using short interfering nucleic acid (sina): This invention relates to compounds, compositions, and methods useful for modulating tumor necrosis factor and/or tumor necrosis factor receptor gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways... Agent:

20120004404 - Radiolabelling methods: The present invention relates to the field of [18F] radiofluorination chemistry for the preparation of Positron Emission Tomography (PET) radioligands and [18F] radiofluorinating reagents. The invention further provides kits for preparation of the same.... Agent:

20120004405 - Compounds having activity in correcting mutant cftr cellular processing: The present invention relates to a compound which is characterized by the formula (I) or a pharmaceutically acceptable salt, solvate, hydrate thereof, wherein the ring systems A and B are independently selected from a monosaccharide, aryl (preferably phenyl), a heteroaryl or cycloalkyl (preferably cyclohexan), preferably with all substituents in equatorial... Agent:

20120004406 - Cellulose crosslinked fibers with reduced fiber knots manufactured from plasma treated pulpsheets: An intrafiber crosslinked cellulose pulp fiber manufactured from plasma-treated pulp sheet. The crosslinked fiber can have lower sonic knots than an untreated pulp sheet.... Agent: Weyerhaeuser Nr Company